Literature DB >> 12452832

Involvement of CD27/CD70 interactions in antigen-specific cytotoxic T-lymphocyte (CTL) activity by perforin-mediated cytotoxicity.

S Yamada1, K Shinozaki, K Agematsu.   

Abstract

CD27 molecules are shown to be essential in the regulation of the death, activation and differentiation of T and B cells. However, the influence of CD27 on cytotoxic T-cell function remains obscure. Autologous EBV transformed B-cell lines (LCL), which highly express CD27 ligand CD70, here stimulated T cells and induced the cytotoxic T-lymphocyte (CTL) activity via T-cell antigen receptors (TCR). The cytotoxicity against LCL was diminished when anti-CD70 blocking MoAb was added initially in the culture. Resting T cells killed more CD70-transfected P815 cells than wild type P815 cells in the presence of anti-CD3 MoAb as measured by a 4-h 51Cr release assay, and the cytotoxicity of both of the cell populations completely disappeared in the presence of concanamycin A (CMA). The expression of the perforin by the LCL-induced CTL in the presence of anti-CD70 blocking MoAb was diminished as compared with that without the blockage of CD27/CD70 interactions. The CTL induced by LCL did not kill Fas-transfected WR cells. CD27 signalling in the T cells did not affect Fas ligand (FasL) mRNA expression, LAK activity and IFN-gamma synthesis in humans. Our data demonstrate that CD27/CD70 interactions enhance the cytotoxicity of CTL in the induction phase through enhancement of killing activity induced via the perforin-dependent mechanism, but not via the Fas/FasL system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452832      PMCID: PMC1906551          DOI: 10.1046/j.1365-2249.2002.02012.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  CD27: a memory B-cell marker.

Authors:  K Agematsu; S Hokibara; H Nagumo; A Komiyama
Journal:  Immunol Today       Date:  2000-05

2.  Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27- human T cells.

Authors:  P A Baars; L M Ribeiro Do Couto; J H Leusen; B Hooibrink; T W Kuijpers; S M Lens; R A van Lier
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

3.  CD27-mediated activation of murine NK cells.

Authors:  K Takeda; H Oshima; Y Hayakawa; H Akiba; M Atsuta; T Kobata; K Kobayashi; M Ito; H Yagita; K Okumura
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

4.  Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.

Authors:  A Gustafsson; V Levitsky; J Z Zou; T Frisan; T Dalianis; P Ljungman; O Ringden; J Winiarski; I Ernberg; M G Masucci
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

5.  Characterization of human inducible costimulator ligand expression and function.

Authors:  A Aicher; M Hayden-Ledbetter; W A Brady; A Pezzutto; G Richter; D Magaletti; S Buckwalter; J A Ledbetter; E A Clark
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

6.  Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.

Authors:  K Vandenborre; S W Van Gool; A Kasran; J L Ceuppens; M A Boogaerts; P Vandenberghe
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

7.  Later development of Fas ligand-mediated cytotoxicity as compared with granule-mediated cytotoxicity during the maturation of natural killer cells.

Authors:  T Nakazawa; K Agematsu; A Yabuhara
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

8.  Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.

Authors:  B Motyka; G Korbutt; M J Pinkoski; J A Heibein; A Caputo; M Hobman; M Barry; I Shostak; T Sawchuk; C F Holmes; J Gauldie; R C Bleackley
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

9.  HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.

Authors:  V Appay; D F Nixon; S M Donahoe; G M Gillespie; T Dong; A King; G S Ogg; H M Spiegel; C Conlon; C A Spina; D V Havlir; D D Richman; A Waters; P Easterbrook; A J McMichael; S L Rowland-Jones
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

10.  Expression of the functional soluble form of human fas ligand in activated lymphocytes.

Authors:  M Tanaka; T Suda; T Takahashi; S Nagata
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

View more
  11 in total

1.  Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.

Authors:  Jianping Huang; Keith W Kerstann; Mojgan Ahmadzadeh; Yong F Li; Mona El-Gamil; Steven A Rosenberg; Paul F Robbins
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

2.  Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency.

Authors:  Mohammed F Alosaimi; Manfred Hoenig; Faris Jaber; Craig D Platt; Jennifer Jones; Jacqueline Wallace; Klaus-Michael Debatin; Ansgar Schulz; Eva Jacobsen; Peter Möller; Hanan E Shamseldin; Ferdous Abdulwahab; Niema Ibrahim; Hosam Alardati; Faisal Almuhizi; Ibraheem F Abosoudah; Talal A Basha; Janet Chou; Fowzan S Alkuraya; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2019-03-11       Impact factor: 10.793

Review 3.  Costimulation signals for memory CD8+ T cells during viral infections.

Authors:  Priyanka A Duttagupta; Alina C Boesteanu; Peter D Katsikis
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

4.  A single-cell and spatially resolved atlas of human breast cancers.

Authors:  Sunny Z Wu; Ghamdan Al-Eryani; Daniel Lee Roden; Simon Junankar; Kate Harvey; Alma Andersson; Aatish Thennavan; Chenfei Wang; James R Torpy; Nenad Bartonicek; Taopeng Wang; Ludvig Larsson; Dominik Kaczorowski; Neil I Weisenfeld; Cedric R Uytingco; Jennifer G Chew; Zachary W Bent; Chia-Ling Chan; Vikkitharan Gnanasambandapillai; Charles-Antoine Dutertre; Laurence Gluch; Mun N Hui; Jane Beith; Andrew Parker; Elizabeth Robbins; Davendra Segara; Caroline Cooper; Cindy Mak; Belinda Chan; Sanjay Warrier; Florent Ginhoux; Ewan Millar; Joseph E Powell; Stephen R Williams; X Shirley Liu; Sandra O'Toole; Elgene Lim; Joakim Lundeberg; Charles M Perou; Alexander Swarbrick
Journal:  Nat Genet       Date:  2021-09-06       Impact factor: 41.307

5.  Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection.

Authors:  Anders Rosén; Ann-Charlotte Bergh; Peter Gogok; Chamilly Evaldsson; Anna Lanemo Myhrinder; Eva Hellqvist; Abu Rasul; Magnus Björkholm; Mattias Jansson; Larry Mansouri; Anquan Liu; Bin Tean Teh; Richard Rosenquist; Eva Klein
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

6.  Evidence for CD19B-CD8T cell interactions in blood and tissues from patients with GvHD.

Authors:  S Deola; C Cugno; P Comoli; I Guido; L Rubert; M Zecca; D Zanolini; A Follenzi; M Langes; G Negri; M Tauber; I Pusceddu; I Cavattoni; M Svaldi; G U Grigoleit; E Baumeister; E Wang; S Rutella; F M Marincola
Journal:  Bone Marrow Transplant       Date:  2016-11-07       Impact factor: 5.483

7.  The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.

Authors:  Sangeeta K Bisheshar; Emma J De Ruiter; Lot A Devriese; Stefan M Willems
Journal:  Oncoimmunology       Date:  2020-04-23       Impact factor: 8.110

Review 8.  Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.

Authors:  Ilse Van Brussel; Zwi N Berneman; Nathalie Cools
Journal:  Mediators Inflamm       Date:  2012-07-18       Impact factor: 4.711

9.  Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation.

Authors:  Ramon Arens; Koen Schepers; Martijn A Nolte; Michiel F van Oosterwijk; René A W van Lier; Ton N M Schumacher; Marinus H J van Oers
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

Review 10.  New emerging targets in cancer immunotherapy: CD27 (TNFRSF7).

Authors:  Angelika M Starzer; Anna S Berghoff
Journal:  ESMO Open       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.